Obstet Gynecol (1990) 76(2):296301
Cost, insurance coverage, and individual tolerance often decide which drug a patient starts on
GLP-1 RAs have demonstrated favorable trends toward improving endocrine and metabolic outcomes, including reductions in ALT, AST, HbA1c, body weight, BMI, LFC, and IHA
His power numbers on rides suffered at first
[8] [9] Women of reproductive potential should use non-oral contraceptives or add a barrier method for 4 weeks after initiation and for 4 weeks after each dose escalation
TRT comes in many forms including oral, topical, and most commonly, injectable